Autoimmune pancerebellitis as an immune-related adverse event: an illustrative case
Immune checkpoint inhibitors have already proved their effectiveness in the treatment of various forms of cancer, and every day their use is becoming more and more prevalent. Unfortunately, every effective treatment has its side effects, and immunotherapy is no exception. In this article, the autho...
Saved in:
Main Authors: | D. Valančius, I. Zagorskienė, A. Klimašauskienė |
---|---|
Format: | Article |
Language: | English |
Published: |
Vilnius University Press
2021-12-01
|
Series: | Neurologijos seminarai |
Subjects: | |
Online Access: | https://www.journals.vu.lt/neurologijos_seminarai/article/view/27611 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune checkpoint inhibitors in cancer patients with autoimmune disease: Safety and efficacy
by: Jiayuan Le, et al.
Published: (2025-12-01) -
Autoimmune encephalitis: case reports of anti-NMDAR and anti-CASPR2 encephalitides and literature review
by: J. Kazlauskaitė, et al.
Published: (2021-12-01) -
The role of BATF in immune cell differentiation and autoimmune diseases
by: Xiaomeng Wang, et al.
Published: (2025-01-01) -
Anti-amphiphysin antibody-induced paraneoplastic-autoimmune encephalitis: case report and literature review
by: E. Kavaliauskaitė, et al.
Published: (2021-12-01) -
Assessment of clinical prognosis in autoimmune encephalitis: Girona score
by: Gary Álvarez Bravo, et al.
Published: (2025-01-01)